MedPath

Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65

Not Applicable
Conditions
Cervical Cancer Screening
HPV Infection
Interventions
Diagnostic Test: HPV self-sampling
Registration Number
NCT05414929
Lead Sponsor
Université de Sherbrooke
Brief Summary

We propose a cross-sectional study to explore the acceptability and feasibility of HPV self-sampling among Quebec women. The study will invite eligible women to self-sample for HPV at home. The HPV risk factors of patients included in the study will be taken into consideration (vaccination, smoking, number of partners, date of last screening, etc.).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
400
Inclusion Criteria
  • Speak and understand French without help

    • Have internet access (for completing forms)
    • Have a mailing address
Exclusion Criteria
  • Known positive HPV status • Have already had a hysterectomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
HPV self-sampling groupHPV self-sampling-
Primary Outcome Measures
NameTimeMethod
Evaluate the acceptability of HPV self-sampling by patients2 months following recruitment

percentage of patients who prefer HPV testing to traditional cytology

Secondary Outcome Measures
NameTimeMethod
Calculate the HPV positivity rate in a population sample2 months following recruitment
Evaluate the percentage of samples collected correctly by patients2 months following recruitment
Evaluate the return rate of mailed kits2 months following recruitment

Trial Locations

Locations (1)

Centre Hospitalier Universitaire de Sherbrooke

🇨🇦

Sherbrooke, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath